| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
29,726 |
24,861 |
$984K |
| 99441 |
|
8,260 |
6,481 |
$342K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,019 |
1,934 |
$121K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
4,928 |
4,673 |
$120K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,511 |
1,473 |
$105K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,207 |
1,164 |
$74K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,921 |
3,682 |
$53K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
3,850 |
3,669 |
$50K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
715 |
681 |
$44K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
586 |
531 |
$31K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,020 |
1,927 |
$29K |
| 99050 |
|
576 |
546 |
$24K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,232 |
1,168 |
$19K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
691 |
641 |
$17K |
| 92567 |
|
1,300 |
1,242 |
$16K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
289 |
277 |
$14K |
| 99188 |
|
319 |
309 |
$9K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
610 |
561 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
134 |
123 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
293 |
275 |
$7K |
| 99174 |
|
337 |
326 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
49 |
45 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
83 |
77 |
$1K |
| 81000 |
|
512 |
490 |
$859.46 |
| 90633 |
|
817 |
770 |
$655.81 |
| 90651 |
|
307 |
289 |
$371.00 |
| 90658 |
|
25 |
25 |
$340.72 |
| 90686 |
|
595 |
560 |
$303.25 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
16 |
14 |
$270.32 |
| 90648 |
|
531 |
513 |
$217.17 |
| 90670 |
|
483 |
467 |
$210.01 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
16 |
16 |
$199.58 |
| 90723 |
|
195 |
192 |
$106.40 |
| 90734 |
|
345 |
335 |
$70.91 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
79 |
75 |
$58.47 |
| 90680 |
|
69 |
69 |
$56.23 |
| 90710 |
|
162 |
154 |
$35.75 |
| 90715 |
|
90 |
89 |
$0.00 |
| 90685 |
|
29 |
29 |
$0.00 |
| 90696 |
|
29 |
25 |
$0.00 |
| 90620 |
|
36 |
36 |
$0.00 |